文献速递头颈部肿瘤放疗放疗物理与技术

基于氟-18-氟代脱氧葡萄糖正电子发射断层显像/计算机断层显像的生物靶区:一个伪命题?

Biological target volume based on fluorine-18-fluorode-oxyglucose positron emission tomography/computed tomography imaging: a spurious proposition?
PubMed 文献 · Radiat Oncol · 2023-02-21

该回顾性研究纳入33例初诊及局部复发时均行18F-FDG-PET/CT的鼻咽癌患者,通过形变配准匹配原发与复发灶图像,评估高代谢区域是否为复发关键。结果显示82.82%(27/33)局部复发病灶与高FDG摄取区重叠体积<50%,96.97%(32/33)与原发性肿瘤重叠>20%,中位交叉率达71.74%。作者认为18F-FDG-PET/CT可能不是基于等值线剂量推量的最佳影像模态,联合其他功能影像或可更准确勾画生物靶区。

要点

  • 82.82%(27/33)局部复发病灶与高FDG摄取区重叠体积<50%。
  • 96.97%(32/33)局部复发病灶与原发肿瘤重叠体积>20%,中位交叉率达71.74%。
  • 作者认为18F-FDG-PET/CT或非基于等值线剂量推量的最佳影像模态。

核心结论

  • 18F-FDG-PET/CT可能是自动勾画靶区的有力工具,但可能不是基于适用等值线进行剂量推量放疗的最佳影像模态。
  • 联合其他功能影像或可更准确地勾画生物靶区(BTV)。

研究设计与样本

  • 回顾性研究,纳入33例初诊及局部复发时均行18F-FDG-PET/CT的鼻咽癌(NPC)患者。
  • 采用形变配准方法匹配原发与复发灶的配对18F-FDG-PET/CT图像,以确定两病灶间的交叉失败率。

主要发现

  • Vpri(SUV阈值2.5的原发肿瘤体积)、Vhigh(SUV50%max等值线的高FDG摄取体积)和Vrecur(SUV阈值2.5的复发肿瘤体积)的中位体积分别为22.85、5.57和9.98 cm3。
  • Vrecur∩high交叉失败率显示82.82%(27/33)的局部复发病灶与高FDG摄取区重叠体积<50%。
  • Vrecur∩pri交叉失败率显示96.97%(32/33)的局部复发病灶与原发肿瘤病灶重叠体积>20%,中位交叉率高达71.74%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess whether the high metabolic region of fluorine-18-fluorode-oxyglucose (18F-FDG) in the primary lesion is the crux for recurrence in patients with nasopharyngeal carcinoma (NPC), to assess the feasibility and rationale for use of biological target volume (BTV) based on 18F-FDG positron emission tomography/computed tomography (18F-FDG-PET/CT). METHODS: The retrospective study included 33 patients with NPC who underwent 18F-FDG-PET/CT at the time of initial diagnosis as well as the time of diagnosis of local recurrence. Paired 18F-FDG-PET/CT images for primary and recurrent lesion were matched by deformation coregistration method to determine the cross-failure rate between two lesions. RESULTS: The median volume of the Vpri (primary tumor volume using the SUV thresholds of 2.5), the Vhigh (the volume of high FDG uptake using the SUV50%max isocontour), and the Vrecur (the recurrent tumor volume using the SUV thresholds of 2.5) were 22.85, 5.57, and 9.98 cm3, respectively. The cross-failure rate of Vrecur∩high showed that 82.82% (27/33) of local recurrent lesions had < 50% overlap volume with the region of high FDG uptake. The cross-failure rate of Vrecur∩pri showed that 96.97% (32/33) of local recurrent lesions had > 20% overlap volume with the primary tumor lesions and the median cross rate was up to 71.74%. CONCLUSION: 18F-FDG-PET/CT may be a powerful tool for automatic target volume delineation, but it may not be the optimal imaging modality for dose escalation radiotherapy based on applicable isocontour. The combination of other functional imaging could delineate the BTV more accurately.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Xu T, Feng Y, Hong H, et al. Biological target volume based on fluorine-18-fluorode-oxyglucose positron emission tomography/computed tomography imaging: a spurious proposition? Radiat Oncol. 2023. PMID: 36810119. doi:10.1186/s13014-023-02225-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。